Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Stem cell therapy for CVDs: Advances persist, challenges remain Jonathan Seltzer, MD, on behalf of the Cardiac Safety Research Consortium
• FDA workshop focuses on cancer immunotherapy-associated myocarditis, other CV toxicities Javid J. Moslehi, MD; Laleh Amiri-Kordestani, MD
• Fulminant myocarditis related to immunotherapy Wendy Bottinor, MD; Javid J. Moslehi, MD
• Almonds, dark chocolate reduce CHD risk in adults with overweight, obesity
• Antidepressants increase risk for recurrent events in long QT syndrome
• CRESCENT-II: Tiered cardiac CT protocol more efficient, faster than functional testing
• DAPT plus newer oral anticoagulants increases bleeding risk in ACS
• Early menarche, other reproductive factors increase risk for CVD
• Elevated Lp(a) confers risk for ischemic stroke but not AF
• ESC risk model reduces ICD use in hypertrophic cardiomyopathy
• Ezetimibe produces strongest CV benefit in patients with diabetes
• Heightened efforts for screening, interventions may decrease global CVD burden
• Influenza increases risk for acute MI
• Lifetime risk for AF greater than previously thought
• Mental stress relates to myocardial ischemia in women
• Mortality rates higher in unmarried patients with CAD
• Polygenic risk score predicts early-onset CAD
• Relationship quality affects CVD risk factors in men
• Silent MI linked to increased HF risk
• Valve repair with annulus stabilization improves outcomes for aortic valve regurgitation
• Vigorous exercise may reverse cardiac effects of sedentary lifestyle
• Mentoring crucial for growth within cardiology specialty
• Inflammation and CVD: Recent data heighten interest in effects, new strategies
• Trial Scorecard: ACTIVE A
• Trial Scorecard: BIOSTAT-CHF
• Trial Scorecard: DANAMI-3 Substudy
• Trial Scorecard: ENSURE-AF
• Trial Scorecard: GOLIATH
• Trial Scorecard: IMPACT
• Trial Scorecard: RESTYLE-HCM
• Trial Scorecard: WIN-TAVI